APSR2026-63

 
Late-Breaking
Submitted
Oral Presentation
AO03-001
 
 
https://storage.unitedwebnetwork.com/files/1285/1201302-46903-APSR26_COPD_433834.pptx
Format: PPTX Only
 
Format: PDF Only
07. COPD
8

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Yue Hu * Capital medical university Department of Immunology Beijing China Yantai Yuhuangding Hospita Department of Otorhinolaryngology, Head and Neck Surgery Yantai China
Yunqi Li - Beijing Chaoyang Hospital, Capital Medical University Department of Immunology Beijing China
Qin Li - Yanjing Medical College, Capital Medical Universityersity Department of Laboratory Beijing China
Chris Corrigan - King’s College London Faculty of Life Sciences & Medicine, London United Kingdom
Jing Yuan - Capital medical university Capital Center for Children’s Health Beijing China
Ye Cui - Capital medical university Department of Immunology Beijing China
Wei Wang - Capital medical university Department of Immunology Beijing Chile
Sun Ying - Capital medical university Department of Immunology Beijing China
 
 
 
 
 
 
 
Presenting Author Details
Yue
Hu
15712927157@163.com
+8615712927157
Under 30
China
Original Research
Xanthine derived from the airway microbiota promotes type 17 immunity-dependent, autoimmune airways inflammation in COPD
Maximum 25 words
Abstract Content
While the airways microbiota is suspected to contribute to the pathogenesis of COPD, the relevant mechanisms remain poorly characterised. Our study addresses the role of xanthine, a metabolite produced by the predominant airways bacteria detected clinically in COPD, in promoting type 17 immunity-dependent, autoimmune airways inflammation.
Murine airways were challenged pernasally with culture supernatants of COPD-relevant airways bacteria and local and systemic inflammatory responses were examined. Since untargeted metabolomic analysis identified xanthine as the predominant, common microbiota-derived metabolite, murine airways were then challenged with xanthine dehydrogenase (Xdh) gene knockout bacteria and xanthine itself.
Airways challenge with supernatants of Streptococcus pneumoniae (Sp), Staphylococcus aureus (Sa), Moraxella catarrhalis (Mc), Pseudomonasaeruginosa (Pa) and Haemophilus influenzae (Hin) resulted in a uniform inflammatory response suggestive of a common mechanism most closely reflecting activation of Th17 cells. Untargeted metabolomic analysis identified xanthine as the predominant, common microbiota-derived metabolite. Production of xanthine correlated with that of multiple specific antibodies while challenge with Pa mutants with knockout of the Xdh gene, increasing xanthine production, as well as xanthine itself, augmented airways inflammation and antibody production, together with increased local Th17 cell differentiation, IL-17A production and elevated local expression of xanthine oxidase, which converts xanthine to uric acid, the end product of urate metabolism, principally by airways epithelial cells and macrophages.
Products of airways bacteria, principally xanthine, promote host autoimmune responses relevant to the progression of COPD. These are potential targets for antibacterial and metabolic approaches to COPD prophylaxis and therapy.
 
 
 
 
 
No
No
 
JPG or JPEG or PNG format ONLY
chronic obstructive pulmonary disease, lung microbiota-host interactions, xanthine
maximum 3 keywords and no abbreviations, separated by commas
 
242